Report cover image

APAC Dyspepsia Drug Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published May 01, 2023
Length 393 Pages
SKU # DAABD18011501

Description

APAC Dyspepsia Drug Market - Industry Trends and Forecast to 2030


Asia-Pacific dyspepsia drug market is expected to reach USD 183,671.18 thousand by 2030 from USD 114,763.07 thousand in 2022, growing at a CAGR of 6.1% during the forecast period of 2023 to 2030.
Market Segmentation:
Asia-Pacific Dyspepsia Drug Market, By Type (Organic Dyspepsia, Non-Ulcer Dyspepsia, Drug Induced Dyspepsia, and Others), Treatment Type (Medication and Surgery), Drug Type (Branded and Generic), Prescription (Without Prescription Drugs and Prescription Drugs), Route of Administration (Oral and Injectable), Gender (Male and Female), End-User (Hospitals, Clinics, Homecare settings, Specialty Clinics, Ambulatory Surgical Centers, Academic and Government Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, New Zealand, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030.



Overview of Asia-Pacific Dyspepsia Drug Market Dynamics:

Driver
• Increasing prevalence of dyspepsia

Restrain

• Possible side effects of the drugs used for dyspepsia

Opportunity

• Growing aging population


Market Players:

Some of the key market players operating in the Asia-Pacific dyspepsia drug market are listed below:

• Abbott
• Bayer AG
• Cadila Pharmaceuticals
• Sanofi
• Lupin
• Perrigo Company plc
• Reckitt Benckiser
• AstraZeneca
• Procter & Gamble
• Otsuka Pharmaceutical Co., Ltd.
• Others

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

393 Pages
1 Introduction 85
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Asia-pacific Dyspepsia Drug Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation 91
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Type Lifeline Curve
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Market End-user Coverage Grid
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary 104
4 Premium Insight 107
4.1 Pestel Analysis
4.2 Porter’s Five Forces
5 Epidemiology 110
6 Problems In The Management Of Dyspepsia 111
7 Industry Insights: 112
8 Asia-pacific Dyspepsia Drug Market, Regulation 113
9 Market Overview 116
9.1 Drivers
9.1.1 Increasing Prevalence Of Dyspepsia
9.1.2 Rise In The Adoption Of Unhealthy Lifestyle
9.1.3 Increase In The Prevalence Of Metabolic Disorders
9.2 Restraints
9.2.1 Possible Side Effects Of The Drugs Used For Dyspepsia
9.2.2 Increasing Preference For Natural And Herbal Remedies
9.3 Opportunities
9.3.1 Growing Aging Population
9.3.2 Rise In The Drug Approval
9.4 Challenges
9.4.1 Lack Of Awareness About Dyspepsia Among The Population
9.4.2 Stringent Regulations
10 Asia-pacific Dyspepsia Drug Market, By Type 124
10.1 Overview
10.2 Non-ulcer Dyspepsia
10.3 Organic Dyspepsia
10.4 Drug Induced Dyspepsia
10.5 Others
11 Asia-pacific Dyspepsia Drug Market, By Treatment Type 131
11.1 Overview
11.2 Medication
11.2.1 Drugs
11.2.1.1 Antacids
11.2.1.1.1 Proton Pump Inhibitors (Ppi’s)
11.2.1.1.1.1 Omeprazole
11.2.1.1.1.2 Lansoprazole
11.2.1.1.1.3 Esomeprazole
11.2.1.1.1.4 Others
11.2.1.1.2 H2 Blockers
11.2.1.1.2.1 Cimetidine
11.2.1.1.2.2 Famotidine
11.2.1.1.2.3 Nizatidine
11.2.1.1.2.4 Ranitidine
11.2.1.1.2.5 Others
11.2.1.2 Gastric Prokinetic Gendernts
11.2.1.2.1 Mosapride Citrate
11.2.1.2.2 Metoclopramide
11.2.1.2.3 Cisapride
11.2.1.2.4 Itopride Hydrochloride
11.2.1.2.5 Domperidone
11.2.1.2.6 Others
11.2.1.3 Antibiotics
11.2.1.3.1 Refaximin
11.2.1.3.2 Amoxicillin
11.2.1.3.3 Clarithromycin
11.2.1.3.4 Metronidazole
11.2.1.3.5 Levofloxacin
11.2.1.3.6 Tetracycline
11.2.1.3.7 Others
11.2.1.4 Others
11.2.2 Non- Drugs
11.2.2.1 Probiotics
11.2.2.1.1 Lactobacillus
11.2.2.1.2 Bifidobacterium
11.2.2.1.3 Bacillus
11.2.2.1.4 Streptococcus
11.2.2.1.5 Others
11.2.2.2 Prebiotics
11.3 Surgery
12 Asia-pacific Dyspepsia Drug Market, By Drug Type 144
12.1 Overview
12.2 Generic
12.3 Branded
13 Asia-pacific Dyspepsia Drug Market, By Prescription 150
13.1 Overview
13.2 Without Prescription Drugs
13.3 Prescription Drugs
14 Asia-pacific Dyspepsia Drug Market, By Route Of Administration 156
14.1 Overview
14.2 Oral
14.2.1 Tablets
14.2.2 Capsules
14.3 Injectable
15 Asia-pacific Dyspepsia Drug Market, By Gender 162
15.1 Overview
15.2 Female
15.2.1 30-50 Years
15.2.2 More Than 50 Years
15.2.3 Age Less Than 30
15.3 Male
15.3.1 30-50 Years
15.3.2 More Than 50 Years
15.3.3 Age Less Than 30
16 Asia-pacific Dyspepsia Drug Market, By End User 169
16.1 Overview
16.2 Hospitals
16.2.1 Type
16.2.1.1 Public
16.2.1.2 Private
16.2.2 Tier
16.2.2.1 Tier 3
16.2.2.2 Tier 2
16.2.2.3 Teir 1
16.3 Clinics
16.4 Homecare Settings
16.5 Specialty Clinics
16.6 Ambulatory Centers
16.7 Academic And Government Research Institutes
16.8 Others
17 Asia-pacific Dyspepsia Drug Market, By Distribution Channel 179
17.1 Overview
17.2 Retail Sales
17.2.1 Reatil Pharmacy
17.2.2 Hospital Pharmacy
17.2.3 Online Pharmacy
17.3 Direct Tender
18 Asia-pacific Dyspepsia Drug Market, By Region 185
18.1 Asia-pacific
18.1.1 Japan
18.1.2 China
18.1.3 South Korea
18.1.4 India
18.1.5 Australia
18.1.6 New Zealand
18.1.7 Singapore
18.1.8 Thailand
18.1.9 Indonesia
18.1.10 Malaysia
18.1.11 Philippines
18.1.12 Vietnam
18.1.13 Taiwan
18.1.14 Rest Of Asia-pacific
19 Asia-pacific Dyspepsia Drug Market, Company Landscape 345
19.1 Company Share Analysis: Asia-pacific
20 Swot Analysis 346
21 Asia-pacific Dyspepsia Drug Market, Company Profilings 347
21.1 Sanofi
21.1.1 Company Snapshot
21.1.2 Revenue Analysis
21.1.3 Company Share Analysis
21.1.4 Product Portfolio
21.1.5 Recent Development
21.2 Lupin
21.2.1 Company Snapshot
21.2.2 Revenue Analysis
21.2.3 Company Share Analysis
21.2.4 Product Portfolio
21.2.5 Recent Developments
21.3 Mankind Pharma
21.3.1 Company Snapshot
21.3.2 Revenue Analysis
21.3.3 Company Share Analysis
21.3.4 Product Portfolio
21.3.5 Recent Development
21.4 Astrazeneca
21.4.1 Company Snapshot
21.4.2 Revenue Analysis
21.4.3 Company Share Analysis
21.4.4 Product Portfolio
21.4.5 Recent Development
21.5 Bayer Ag
21.5.1 Company Snapshot
21.5.2 Revenue Analysis
21.5.3 Company Share Analysis
21.5.4 Product Portfolio
21.5.5 Recent Development
21.6 Abbott
21.6.1 Company Snapshot
21.6.2 Revenue Analysis
21.6.3 Product Portfolio
21.6.4 Recent Development
21.7 Ani Pharmaceuticals, Inc.
21.7.1 Company Snapshot
21.7.2 Revenue Analysis
21.7.3 Product Portfolio
21.7.4 Recent Development
21.8 Aosaikang Pharmaceutical Co., Ltd.
21.8.1 Company Snapshot
21.8.2 Revenue Analysis
21.8.3 Product Portfolio
21.8.4 Recent Development
21.9 Asterisk Laboratories (I) Pvt. Ltd
21.9.1 Company Snapshot
21.9.2 Product Portfolio
21.9.3 Recent Development
21.10 Cadila Pharmaceuticals
21.10.1 Company Snapshot
21.10.2 Revenue Analysis
21.10.3 Company Share Analysis
21.10.4 Product Portfolio
21.10.5 Recent Development
21.11 Hanmi Pharm. Co., Ltd.
21.11.1 Company Snapshot
21.11.2 Revenue Analysis
21.11.3 Product Portfolio
21.11.4 Recent Development
21.12 Mcneil Consumer Pharmaceuticals Co. (A Subsidiary Of Johnson & Johnson Services, Inc.)
21.12.1 Company Snapshot
21.12.2 Revenue Analysis
21.12.3 Product Portfolio
21.12.4 Recent Development
21.13 Otsuka Pharmaceutical Co., Ltd.
21.13.1 Company Snapshot
21.13.2 Revenue Analysis
21.13.3 Product Portfolio
21.13.4 Recent Development
21.14 Perrigo Company Plc
21.14.1 Company Snapshot
21.14.2 Revenue Analysis
21.14.3 Product Portfolio
21.14.4 Recent Development
21.15 Prestige Consumer Healthcare, Inc.
21.15.1 Company Snapshot
21.15.2 Revenue Analysis
21.15.3 Product Portfolio
21.15.4 Recent Development
List Of Tables
Table 1 Asia-pacific Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 2 Asia-pacific Non-ulcer Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 3 Asia-pacific Organic Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 4 Asia-pacific Drug Induced Dyspepsia In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 5 Asia-pacific Others In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 6 Asia-pacific Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 7 Asia-pacific Medication In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 8 Asia-pacific Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 9 Asia-pacific Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 10 Asia-pacific Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 11 Asia-pacific Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 12 Asia-pacific H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 13 Asia-pacific Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 14 Asia-pacific Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 15 Asia-pacific Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 16 Asia-pacific Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 17 Asia-pacific Surgery In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 18 Asia-pacific Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 19 Asia-pacific Generic In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 20 Asia-pacific Branded In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 21 Asia-pacific Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand)
Table 22 Asia-pacific Without Prescription Drugs In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 23 Asia-pacific Prescription Drugs In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 24 Asia-pacific Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 25 Asia-pacific Oral In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 26 Asia-pacific Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 27 Asia-pacific Injectable In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 28 Asia-pacific Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand)
Table 29 Asia-pacific Female In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 30 Asia-pacific Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 31 Asia-pacific Male In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 32 Asia-pacific Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 33 Asia-pacific Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand)
Table 34 Asia-pacific Hospitals In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 35 Asia-pacific Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 36 Asia-pacific Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand)
Table 37 Asia-pacific Clinics In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 38 Asia-pacific Homecare Settings In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 39 Asia-pacific Specialty Clinics In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 40 Asia-pacific Ambulatory Centers In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 41 Asia-pacific Academic And Government Research Institutes In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 42 Asia-pacific Others In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 43 Asia-pacific Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 44 Asia-pacific Retail Sales In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 45 Asia-pacific Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 46 Asia-pacific Direct Tender In Dyspepsia Drug Market, By Region, 2021-2030 (Usd Thousand)
Table 47 Asia-pacific Dyspepsia Drug Market, By Country, 2021-2030 (Usd Thousand)
Table 48 Asia-pacific Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 49 Asia-pacific Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 50 Asia-pacific Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 51 Asia-pacific Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 52 Asia-pacific Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 53 Asia-pacific Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 54 Asia-pacific Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 55 Asia-pacific H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030, (Usd Thousands )
Table 56 Asia-pacific H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 57 Asia-pacific Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 58 Asia-pacific Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 59 Asia-pacific Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 60 Asia-pacific Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 61 Asia-pacific Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 62 Asia-pacific Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 63 Asia-pacific Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 64 Asia-pacific Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 65 Asia-pacific Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand)
Table 66 Asia-pacific Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 67 Asia-pacific Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 68 Asia-pacific Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand)
Table 69 Asia-pacific Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 70 Asia-pacific Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 71 Asia-pacific Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand)
Table 72 Asia-pacific Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 73 Asia-pacific Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand)
Table 74 Asia-pacific Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 75 Asia-pacific Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 76 Japan Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 77 Japan Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 78 Japan Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 79 Japan Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 80 Japan Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 81 Japan Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 82 Japan Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 83 Japan Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 84 Japan H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 85 Japan H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 86 Japan H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 87 Japan Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 88 Japan Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 89 Japan Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 90 Japan Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 91 Japan Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 92 Japan Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 93 Japan Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 94 Japan Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 95 Japan Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 96 Japan Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 97 Japan Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 98 Japan Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand)
Table 99 Japan Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 100 Japan Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 101 Japan Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand)
Table 102 Japan Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 103 Japan Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 104 Japan Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand)
Table 105 Japan Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 106 Japan Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand)
Table 107 Japan Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 108 Japan Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 109 .China Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 110 China Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 111 China Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 112 China Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 113 China Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 114 China Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 115 China Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 116 China Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 117 China H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 118 China H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 119 China H2 Blockers In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 120 China Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 121 China Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 122 China Gastric Prokinetic Gendernts In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 123 China Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 124 China Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 125 China Antibiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 126 China Non Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 127 China Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 128 China Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 129 China Probiotics In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
Table 130 China Dyspepsia Drug Market, By Drug Type, 2021-2030 (Usd Thousand)
Table 131 China Dyspepsia Drug Market, By Prescription, 2021-2030 (Usd Thousand)
Table 132 China Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 133 China Oral In Dyspepsia Drug Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 134 China Dyspepsia Drug Market, By Gender, 2021-2030 (Usd Thousand)
Table 135 China Female In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 136 China Male In Dyspepsia Drug Market, By Age, 2021-2030 (Usd Thousand)
Table 137 China Dyspepsia Drug Market, By End User, 2021-2030 (Usd Thousand)
Table 138 China Hospitals In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 139 China Hospitals In Dyspepsia Drug Market, By Tier, 2021-2030 (Usd Thousand)
Table 140 China Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 141 China Retail Sales In Dyspepsia Drug Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 142 South Korea Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 143 South Korea Dyspepsia Drug Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 144 South Korea Medication In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 145 South Korea Drugs In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 146 South Korea Antacid In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 147 South Korea Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Usd Thousand)
Table 148 South Korea Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Thousand Units)
Table 149 South Korea Proton Pump Inhibitors (Ppi's) In Dyspepsia Drug Market, By Type, 2021-2030 (Asp)
List Of Figures
Figure 1 Asia-pacific Dyspepsia Drug Market: Segmentation
Figure 2 Asia-pacific Dyspepsia Drug Market: Data Triangulation
Figure 3 Asia-pacific Dyspepsia Drug Market: Droc Analysis
Figure 4 Asia-pacific Dyspepsia Drug Market: Asia-pacific Vs. Regional Market Analysis
Figure 5 Asia-pacific Dyspepsia Drug Market: Company Research Analysis
Figure 6 Asia-pacific Dyspepsia Drug Market: Interview Demographics
Figure 7 Asia-pacific Dyspepsia Drug Market: Multivariate Modelling
Figure 8 Asia-pacific Dyspepsia Drug Market: Dbmr Market Position Grid
Figure 9 Asia-pacific Dyspepsia Drug Market: Vendor Share Analysis
Figure 10 Asia-pacific Dyspepsia Drug Market: Market End-user Coverage Grid
Figure 11 Asia-pacific Dyspepsia Drug Market: Segmentation
Figure 12 Increase In The Prevalence Of Metabolic Disorders Is Expected To Drive The Asia-pacific Dyspepsia Drug Market Growth In The Forecast Period From 2023 To 2030
Figure 13 Non-ulcer Dyspepsia Segment Is Expected To Account For The Largest Share Of The Asia-pacific Dyspepsia Drug Market In 2023 & 2030
Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Asia-pacific Dyspepsia Drug Market
Figure 15 Asia-pacific Dyspepsia Drug Market: By Type, 2022
Figure 16 Asia-pacific Dyspepsia Drug Market: By Type, 2023-2030 (Usd Thousand)
Figure 17 Asia-pacific Dyspepsia Drug Market: By Type, Cagr (2023-2030)
Figure 18 Asia-pacific Dyspepsia Drug Market: By Type, Lifeline Curve
Figure 19 Asia-pacific Dyspepsia Drug Market: By Treatment Type , 2022
Figure 20 Asia-pacific Dyspepsia Drug Market: By Treatment Type, 2023-2030 (Usd Thousand)
Figure 21 Asia-pacific Dyspepsia Drug Market: By Treatment Type , Cagr (2023-2030)
Figure 22 Asia-pacific Dyspepsia Drug Market: By Treatment Type , Lifeline Curve
Figure 23 Asia-pacific Dyspepsia Drug Market: By Drug Type, 2022
Figure 24 Asia-pacific Dyspepsia Drug Market: By Drug Type, 2023-2030 (Usd Thousand)
Figure 25 Asia-pacific Dyspepsia Drug Market: By Drug Type, Cagr (2023-2030)
Figure 26 Asia-pacific Dyspepsia Drug Market: By Drug Type, Lifeline Curve
Figure 27 Asia-pacific Dyspepsia Drug Market: By Prescription, 2022
Figure 28 Asia-pacific Dyspepsia Drug Market: By Prescription, 2023-2030 (Usd Thousand)
Figure 29 Asia-pacific Dyspepsia Drug Market: By Prescription, Cagr (2023-2030)
Figure 30 Asia-pacific Dyspepsia Drug Market: By Prescription, Lifeline Curve
Figure 31 Asia-pacific Dyspepsia Drug Market: By Route Of Administration, 2022
Figure 32 Asia-pacific Dyspepsia Drug Market: By Route Of Administration, 2023-2030 (Usd Thousand)
Figure 33 Asia-pacific Dyspepsia Drug Market: By Route Of Administration, Cagr (2023-2030)
Figure 34 Asia-pacific Dyspepsia Drug Market: By Route Of Administration, Lifeline Curve
Figure 35 Asia-pacific Dyspepsia Drug Market: By Gender, 2022
Figure 36 Asia-pacific Dyspepsia Drug Market: By Gender, 2023-2030 (Usd Thousand)
Figure 37 Asia-pacific Dyspepsia Drug Market: By Gender, Cagr (2023-2030)
Figure 38 Asia-pacific Dyspepsia Drug Market: By Gender, Lifeline Curve
Figure 39 Asia-pacific Dyspepsia Drug Market: By End User, 2022
Figure 40 Asia-pacific Dyspepsia Drug Market: By End User, 2023-2030 (Usd Thousand)
Figure 41 Asia-pacific Dyspepsia Drug Market: By End User, Cagr (2023-2030)
Figure 42 Asia-pacific Dyspepsia Drug Market: By End User, Lifeline Curve
Figure 43 Asia-pacific Dyspepsia Drug Market: By Distribution Channel, 2022
Figure 44 Asia-pacific Dyspepsia Drug Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 45 Asia-pacific Dyspepsia Drug Market: By Distribution Channel, Cagr (2023-2030)
Figure 46 Asia-pacific Dyspepsia Drug Market: By Distributi

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us